{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1977-N-0013\" sorted by posted_date descending", "rows": [["FDA-1977-N-0013-0048", "FDA", "FDA-1977-N-0013", "Citizen Petition from GlaxoSmithKline Consumer Healthcare (GSKCH)", "Other", "Citizen Petition", "2017-07-17T04:00:00Z", 2017, 7, "2017-07-17T04:00:00Z", null, "2024-11-12T05:15:25Z", null, 1, 0, "09000064813341f7"], ["FDA-1977-N-0013-0047", "FDA", "FDA-1977-N-0013", "McNeil Consumer Healthcare - Letter", "Other", "Letter(s)", "2012-01-26T05:00:00Z", 2012, 1, "2012-01-26T05:00:00Z", null, "2012-01-26T15:07:32Z", null, 0, 0, "0900006480fa55cd"], ["FDA-1977-N-0013-0046", "FDA", "FDA-1977-N-0013", "Interim Response to GlaxoSmithKline Consumer Healthcare - Letter", "Other", "Letter(s)", "2011-07-21T04:00:00Z", 2011, 7, "2011-07-21T04:00:00Z", null, "2011-07-21T12:31:43Z", null, 0, 0, "0900006480ec80bf"], ["FDA-1977-N-0013-0042", "FDA", "FDA-1977-N-0013", "Citizen Petition from GlaxoSmithKline Consumer Healthcare", "Other", "Citizen Petition", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2019-02-05T12:47:52Z", null, 0, 0, "0900006480c0c71c"], ["FDA-1977-N-0013-0044", "FDA", "FDA-1977-N-0013", "Attachment 2 - Synopsis Report, Study Number A4000685 re: Citizen Petition from GlaxoSmithKline Consumer Healthcare", "Supporting & Related Material", "Background Material", "2011-03-24T04:00:00Z", 2011, 3, null, null, "2019-02-06T16:43:39Z", null, 0, 0, "0900006480c0c908"], ["FDA-1977-N-0013-0045", "FDA", "FDA-1977-N-0013", "Acknowledgment Letter from FDA DDM to GlaxoSmithKline Consumer Healthcare", "Other", "Acknowledgement Letter/Receipt", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2019-02-05T13:13:02Z", null, 0, 0, "0900006480c0c93a"], ["FDA-1977-N-0013-0043", "FDA", "FDA-1977-N-0013", "Attachment 1 - Synopsis Report, Study Number A4000684 re: Citizen Petition from GlaxoSmithKline Consumer Healthcare", "Supporting & Related Material", "Background Material", "2011-03-24T04:00:00Z", 2011, 3, null, null, "2019-02-05T13:00:37Z", null, 0, 0, "0900006480c0c905"], ["FDA-1977-N-0013-0041", "FDA", "FDA-1977-N-0013", "Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment", "Rule", "Final Rule", "2009-11-25T05:00:00Z", 2009, 11, "2009-11-25T05:00:00Z", null, "2019-02-22T12:55:02Z", "E9-28296", 0, 0, "0900006480a5e8d7"], ["FDA-1977-N-0013-0039", "FDA", "FDA-1977-N-0013", "Letter from CHPA to Michael S. Furness of Nonprescription Regulation Development, ONP, CDER/FDA", "Other", "Letter(s)", "2009-08-27T04:00:00Z", 2009, 8, "2009-08-27T04:00:00Z", null, "2019-02-22T13:00:14Z", null, 0, 0, "0900006480a1487c"], ["FDA-1977-N-0013-0040", "FDA", "FDA-1977-N-0013", "Letter from CHPA to Ms. Arlene Solbeck, CDER/FDA", "Other", "Letter(s)", "2009-08-27T04:00:00Z", 2009, 8, "2009-08-27T04:00:00Z", null, "2019-02-22T13:01:02Z", null, 0, 0, "0900006480a14f53"], ["FDA-1977-N-0013-0037", "FDA", "FDA-1977-N-0013", "Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph; Corrections", "Rule", "Correction", "2009-06-30T04:00:00Z", 2009, 6, "2009-06-30T04:00:00Z", null, "2019-02-21T21:46:48Z", "E9-15403", 0, 0, "09000064809e636f"], ["FDA-1977-N-0013-0038", "FDA", "FDA-1977-N-0013", "List of References re: Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph; Corrections", "Other", "List (LST)", "2009-06-30T04:00:00Z", 2009, 6, "2009-06-30T04:00:00Z", null, "2019-02-21T21:50:59Z", null, 0, 0, "09000064809e699e"], ["FDA-1977-N-0013-0021", "FDA", "FDA-1977-N-0013", "Reference 3 - Comment No. EMC1 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T12:47:24Z", null, 0, 0, "0900006480828e3e"], ["FDA-1977-N-0013-0018", "FDA", "FDA-1977-N-0013", "Public Administrative File - Organ-Specific Warnings: Internal Analgesic Antipyretic, and Antihreumatic Drug Products for Over-the Counter Human Use; Final Monograph - Memorandum", "Supporting & Related Material", "BKG-Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2009-04-29T20:19:30Z", null, 0, 0, "09000064808215d4"], ["FDA-1977-N-0013-0019", "FDA", "FDA-1977-N-0013", "Reference 1 - Comment No. C7. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T12:41:34Z", null, 0, 0, "0900006480828df1"], ["FDA-1977-N-0013-0026", "FDA", "FDA-1977-N-0013", "Reference 8 - Comment No. EC2 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T16:16:09Z", null, 0, 0, "0900006480828f68"], ["FDA-1977-N-0013-0033", "FDA", "FDA-1977-N-0013", "Reference 22 - Green, J. L. et al., \"Hepatic Function in Alcoholic Throughout 5 Days of Maximal Therapeutic Dosing of Acetaminophen (APAP),\" Clinical Toxicology. 43:683, 2005. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T16:48:10Z", null, 0, 0, "0900006480829070"], ["FDA-1977-N-0013-0030", "FDA", "FDA-1977-N-0013", "Reference 12 - Comment No. C8 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T16:34:51Z", null, 0, 0, "0900006480828faa"], ["FDA-1977-N-0013-0027", "FDA", "FDA-1977-N-0013", "Reference 9 - Comment No. EREG1 re: background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T12:56:30Z", null, 0, 0, "0900006480828f78"], ["FDA-1977-N-0013-0031", "FDA", "FDA-1977-N-0013", "Reference 56 - Eastern Research Group, Inc. \"Cost Benefit Analysis of Proposed FDA Rule on Over-the-Counter Internal Analgesic, Antipyretic, and Antirheumatic Drug Products; Required Warnings,\" Final Report, October 6, 2004, with Addendum, July 30, 2007. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T13:53:22Z", null, 0, 0, "0900006480829222"], ["FDA-1977-N-0013-0034", "FDA", "FDA-1977-N-0013", "Reference 23 -Dargere, S. et al., \"Lack of Toxicity of Acetaminophen in Patients with Chronic Hepatitis C: A Randomized Controlled Trial,\" Gastroenterology. 118:A947, 2000 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T13:05:17Z", null, 0, 0, "090000648082907d"], ["FDA-1977-N-0013-0022", "FDA", "FDA-1977-N-0013", "Reference 4 - Comment No. EREG4 re: Background Material", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T15:41:42Z", null, 0, 0, "0900006480828e48"], ["FDA-1977-N-0013-0020", "FDA", "FDA-1977-N-0013", "Reference 2 - Comment No. C3. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T15:21:45Z", null, 0, 0, "0900006480828e2b"], ["FDA-1977-N-0013-0028", "FDA", "FDA-1977-N-0013", "Reference 10 - Comment No. C5 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T16:24:22Z", null, 0, 0, "0900006480828f8b"], ["FDA-1977-N-0013-0035", "FDA", "FDA-1977-N-0013", "Reference 24 - \"Action Plan for Liver Disease Research. A Report of the Liver Disease Subcommittee of the Digestive Diseases Interagency Coordinating Committee,\" NIH Publication No. 04-5491, 2004. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T13:08:26Z", null, 0, 0, "0900006480829082"], ["FDA-1977-N-0013-0025", "FDA", "FDA-1977-N-0013", "Reference 7 - Comment No. EC1 re : Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T16:14:04Z", null, 0, 0, "0900006480828eff"], ["FDA-1977-N-0013-0029", "FDA", "FDA-1977-N-0013", "Reference 11 - Comment No. EC4 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T16:33:06Z", null, 0, 0, "0900006480828f97"], ["FDA-1977-N-0013-0017", "FDA", "FDA-1977-N-0013", "Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph", "Rule", "Final Rule", "2009-04-29T04:00:00Z", 2009, 4, "2009-04-29T04:00:00Z", null, "2019-03-20T19:57:29Z", "E9-9684", 0, 0, "090000648096ef53"], ["FDA-1977-N-0013-0023", "FDA", "FDA-1977-N-0013", "Reference 5 - Comment No. C6 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T16:04:41Z", null, 0, 0, "0900006480828e54"], ["FDA-1977-N-0013-0036", "FDA", "FDA-1977-N-0013", "Reference 49 - Comment No. C1 re: Background Material  from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-05T17:45:03Z", null, 0, 0, "09000064808291cf"], ["FDA-1977-N-0013-0032", "FDA", "FDA-1977-N-0013", "Reference 56 - Eastern Research Group, Inc. \"Cost Benefit Analysis of Proposed FDA Rule on Overthe-Counter Internal Analgesic, Antipyretic, and Antirheumatic Drug Products; Required Warnings,\" Final Report, October 6, 2004, with Addendum, July 30, 2007. re: Background Material from FDA (Part 2 of Reference 56)", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T14:05:23Z", null, 0, 0, "0900006480829234"], ["FDA-1977-N-0013-0024", "FDA", "FDA-1977-N-0013", "Reference 6 - Letter from Charles Ganley, FDA, to NSAID NDA Holders, July 2005 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T12:51:03Z", null, 0, 0, "0900006480828ea3"], ["FDA-1977-N-0013-0011", "FDA", "FDA-1977-N-0013", "Submission Table of Contents re: Comment from McNeil Consumer Healthcare", "Supporting & Related Material", "Background Material", "2008-11-07T05:00:00Z", 2008, 11, null, null, "2019-03-20T14:08:38Z", null, 0, 0, "09000064805d80b1"], ["FDA-1977-N-0013-0010", "FDA", "FDA-1977-N-0013", "Background Material - BKG1 - References", "Supporting & Related Material", "BKG-Background Material", "2008-11-07T05:00:00Z", 2008, 11, null, null, "2008-11-07T20:29:50Z", null, 0, 0, "09000064805d7f4a"], ["FDA-1977-N-0013-0001", "FDA", "FDA-1977-N-0013", "Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-12-19T05:00:00Z", 2006, 12, "2006-12-19T05:00:00Z", "2007-06-20T03:59:59Z", "2019-03-23T23:59:29Z", "E6-21855", 0, 0, "09000064805d7f3f"]], "truncated": false, "filtered_table_rows_count": 35, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-1977-N-0013"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1977-N-0013", "results": [{"value": "FDA", "label": "FDA", "count": 35, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1977-N-0013", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 23, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 8, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&document_type=Other", "selected": false}, {"value": "Rule", "label": "Rule", "count": 3, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&document_type=Rule", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1977-N-0013", "results": [{"value": 2009, "label": 2009, "count": 25, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&posted_year=2009", "selected": false}, {"value": 2011, "label": 2011, "count": 5, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&posted_year=2011", "selected": false}, {"value": 2008, "label": 2008, "count": 2, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&posted_year=2008", "selected": false}, {"value": 2006, "label": 2006, "count": 1, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&posted_year=2006", "selected": false}, {"value": 2012, "label": 2012, "count": 1, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&posted_year=2012", "selected": false}, {"value": 2017, "label": 2017, "count": 1, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&posted_year=2017", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0013&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 9.074102155864239, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}